Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Clinical trial NCT02389309 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02389309
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Recurrent Brain Neoplasm Recurrent Malignant Solid Neoplasm Refractory Brain Neoplasm

Start date: 2015-10-05
Primary completion: 2027-10-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.